CervoMed Inc. (NASDAQ:CRVO) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Simply Wall StNov 21 05:56 ET

D. Boral Capital Initiates Coverage On CervoMed With Buy Rating, Announces Price Target of $34

BenzingaNov 18 10:16 ET · Ratings

CervoMed Is Maintained at Buy by Chardan Capital

Dow JonesNov 14 17:48 ET · Ratings

CervoMed Price Target Maintained With a $55.00/Share by Chardan Capital

Dow JonesNov 14 17:48 ET · Ratings

CervoMed Analyst Ratings

BenzingaNov 14 17:37 ET · Ratings

Morgan Stanley Maintains CervoMed(CRVO.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsNov 13 08:36 ET · Ratings